Objectives: To evaluate the combined contribution of brain and cervical cord damage in predicting 5-year clinical worsening in a multicentre cohort of definite multiple sclerosis (MS) patients. Methods: Baseline 3.0T brain and cervical cord T2-weighted and three-dimensional T1-weighted MRI was acquired in 367 patients with MS (326 relapse-onset and 41 progressive-onset) and 179 healthy controls. Expanded Disability Status Scale (EDSS) score was obtained at baseline and after a median follow-up of 5.1 years (IQR=4.8-5.2). At follow-up, patients were classified as clinically stable/worsened according to EDSS changes. Generalised linear mixed models identified predictors of clinical worsening, evolution to secondary progressive (SP) MS and rea...
Cervical cord and brain grey matter atrophy independently associate with long-term MS disability In ...
BACKGROUND: Neuroaxonal loss is a pathological substrate of disability in progressive multiple scler...
ObjectiveA major challenge in multiple sclerosis (MS) research is the understanding of silent progre...
Objective To examine the temporal evolution of spinal cord (SC) atrophy in multiple sclerosis (MS), ...
Upper cervical cord area (UCCA) atrophy is a prognostic marker for clinical progression in longstand...
Background: Spatio-temporal evolution of cord atrophy in multiple sclerosis (MS) has not been invest...
OBJECTIVE: To determine whether brain atrophy and lesion volumes predict subsequent 10 year clinica...
IMPORTANCE: The investigation of cortical gray matter (GM), deep GM nuclei, and spinal cord damage i...
OBJECTIVE: To investigate the longitudinal spinal cord and brain changes in neuromyelitis optica (NM...
As atrophy represents the most relevant driver of progression in multiple sclerosis (MS), we investi...
Objective: To investigate whether spinal cord (SC) lesion load, when quantified on axial images with...
Objective: In multiple sclerosis (MS), cerebral gray matter (GM) atrophy correlates more strongly th...
Background: Spinal cord pathology is an important substrate for long-term disability in multiple scl...
OBJECTIVES: Previous studies have shown that upper cervical cord atrophy (UCCA) occurs in multiple s...
Background: Pathology in the spinal cord of patients with primary progressive multiple sclerosis (PP...
Cervical cord and brain grey matter atrophy independently associate with long-term MS disability In ...
BACKGROUND: Neuroaxonal loss is a pathological substrate of disability in progressive multiple scler...
ObjectiveA major challenge in multiple sclerosis (MS) research is the understanding of silent progre...
Objective To examine the temporal evolution of spinal cord (SC) atrophy in multiple sclerosis (MS), ...
Upper cervical cord area (UCCA) atrophy is a prognostic marker for clinical progression in longstand...
Background: Spatio-temporal evolution of cord atrophy in multiple sclerosis (MS) has not been invest...
OBJECTIVE: To determine whether brain atrophy and lesion volumes predict subsequent 10 year clinica...
IMPORTANCE: The investigation of cortical gray matter (GM), deep GM nuclei, and spinal cord damage i...
OBJECTIVE: To investigate the longitudinal spinal cord and brain changes in neuromyelitis optica (NM...
As atrophy represents the most relevant driver of progression in multiple sclerosis (MS), we investi...
Objective: To investigate whether spinal cord (SC) lesion load, when quantified on axial images with...
Objective: In multiple sclerosis (MS), cerebral gray matter (GM) atrophy correlates more strongly th...
Background: Spinal cord pathology is an important substrate for long-term disability in multiple scl...
OBJECTIVES: Previous studies have shown that upper cervical cord atrophy (UCCA) occurs in multiple s...
Background: Pathology in the spinal cord of patients with primary progressive multiple sclerosis (PP...
Cervical cord and brain grey matter atrophy independently associate with long-term MS disability In ...
BACKGROUND: Neuroaxonal loss is a pathological substrate of disability in progressive multiple scler...
ObjectiveA major challenge in multiple sclerosis (MS) research is the understanding of silent progre...